HOTH - Hoth Therapeutics, Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 1.21

Open

$ 1.22

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.22 - $ 1.27

52 Week Range

$ 0.99 - $ 4.30

Volume

73,393

Average Volume

Market Cap

5.33M

Beta (5Y Monthly)

$ 0.95

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-28-2024	12-31-2023	10-K
2	11-13-2023	09-30-2023	10-Q
3	08-11-2023	06-30-2023	10-Q
4	05-15-2023	03-31-2023	10-Q
5	03-31-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-12-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-29-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	08-11-2021	06-30-2021	10-Q
12	05-13-2021	03-31-2021	10-Q
13	03-16-2021	12-31-2020	10-K
14	11-10-2020	09-30-2020	10-Q
15	08-13-2020	06-30-2020	10-Q
16	05-13-2020	03-31-2020	10-Q
17	03-02-2020	12-31-2019	10-K
18	11-12-2019	09-30-2019	10-Q
19	08-14-2019	06-30-2019	10-Q
20	05-15-2019	03-31-2019	10-Q
21	04-01-2019	12-31-2018	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Hoth...
04/05/2024 10:15:37

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Hoth Therapeutics (NASDAQ:HOTH) with a Buy and maintains $4 pr...

EF Hutton Maintains Buy on Hoth Therapeuti...
04/02/2024 13:03:37

EF Hutton analyst Tim Moore maintains Hoth Therapeutics (NASDAQ:HOTH) with a Buy and raises the price target from $6.5 to $7.

Hoth Therapeutics' Merveille.ai Subsidiary...
03/27/2024 12:28:14

why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Peraso Shares Are Trading Lower By Ove...
03/19/2024 17:48:27

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

why-is-alzheimers-focused-hoth-therapeutics-stock-trading-higher-on-tuesday

Why Is Alzheimer's-Focused Hoth Therapeuti...
03/19/2024 17:01:48

Hoth Therapeutics reveals preclinical findings on HT-ALZ, a potential Alzheimer's therapeutic targeting the Substance P/Neu...

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
03/19/2024 13:05:53

Market-Moving News for March 19th
03/19/2024 12:41:16

CERS: 64% | Cerus Corporation Announces Its ReCePI Phase 3 Trial Of INTERCEPT Blood System Met Its Primary Efficacy Endpoint; S...

Hoth Therapeutics Says HT-ALZ Emerges As ...
03/19/2024 12:22:38

Hoth Therapeutics Announces Data In Comple...
03/19/2024 12:22:15

HT-ALZ emerges as a promising novel solution for combating neuroinflammation and cognitive deficits associated with Alzheimer&#...

Hoth Therapeutics Engages Altasciences To ...
02/26/2024 13:12:38

Hoth's HT-KIT has received FDA Orphan Drug Status and Continues to Show Positive Study Results in Treating Mast Cell-Derive...

HC Wainwright & Co. Initiates Coverage On ...
02/05/2024 11:33:47

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Hoth Therapeutics (NASDAQ:HOTH) with a Buy rating a...

Hoth Therapeutics Received FDA Approval To...
01/18/2024 13:21:32

Patients will be able to enroll in trial at any time and regardless of failure from other therapeutics

On January 8, 2024 Hoth Therapeutics Filed...
01/09/2024 20:05:53

On January 8, 2024 Hoth Therapeutics filed a patent application with the U.S. Patent and Trademark Office ("USPTO") for...

Why Hoth Therapeutics Shares Are Rising Today
12/27/2023 15:37:47

Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares are trading higher after the company announced the expansion of its FDA-cleared f...

Hoth Therapeutics Announces Expansion Of F...
12/27/2023 13:22:25

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, announced today that it has received appro...

Market-Moving News for December 5th
12/05/2023 13:47:51

GTLB: 18% | GitLab shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4...

Hoth Therapeutics Announces It Has Success...
12/05/2023 13:34:47

Hoth Therapeutics Announces Completion Of ...
11/14/2023 13:38:41

Stocks That Hit 52-Week Lows On Thursday
10/05/2023 17:22:02

On Thursday, 369 companies hit new 52-week lows.

Hoth Therapeutics Announces Merveille.ai A...
10/05/2023 14:06:06

The new wholly owned subsidiary will screen for rare disease therapeutics.NEW YORK, Oct. 5, 2023 /PRNewswire/ -- Hoth Therapeut...